Free Trial
Priya Sachdeva

Priya Sachdeva Analyst Performance

Director, Equity Research at UBS Group

Priya Sachdeva is a stock analyst at UBS Group in the medical sector, covering 3 publicly traded companies. Over the past year, Priya Sachdeva has issued 7 stock ratings, including buy and hold recommendations. While full access to Priya Sachdeva's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Priya Sachdeva's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
9 Last 1 Years
Buy Recommendations
66.67% 6 Buy Ratings
Companies Covered
3 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy66.7%6 ratings
Hold33.3%3 ratings
Sell0.0%0 ratings

Out of 9 total stock ratings issued by Priya Sachdeva at UBS Group, the majority (66.7%) have been Buy recommendations, followed by 33.3% Hold.

Exchange Coverage

ExchangePercentageCount
NYSE
66.7% of companies on NYSE
2 companies
NASDAQ
33.3% of companies on NASDAQ
1 company

Priya Sachdeva, an analyst at UBS Group, currently covers 3 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
3 companies
100.0%

Priya Sachdeva of UBS Group specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED INSTRUMENTS
2 companies
66.7%
MED PRODUCTS
1 company
33.3%

Priya Sachdeva's Ratings History at UBS Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Medtronic PLC stock logo
MDT
Medtronic
4/22/2026Lower Price Target$83.23$90.00Neutral
Penumbra, Inc. stock logo
PEN
Penumbra
2/26/2026Reiterated Rating$340.32$374.00Neutral
Penumbra, Inc. stock logo
PEN
Penumbra
1/16/2026Downgrade$359.07Hold
NeuroPace, Inc. stock logo
NPCE
NeuroPace
1/14/2026Reiterated Rating$16.34Buy
NeuroPace, Inc. stock logo
NPCE
NeuroPace
12/16/2025Boost Price Target$15.86$22.00Buy
NeuroPace, Inc. stock logo
NPCE
NeuroPace
12/9/2025Reiterated Rating$16.40$18.00Buy
Penumbra, Inc. stock logo
PEN
Penumbra
7/30/2025Set Price Target$255.54$335.00Buy
Penumbra, Inc. stock logo
PEN
Penumbra
1/21/2025Initiated Coverage$264.08$305.00Buy
NeuroPace, Inc. stock logo
NPCE
NeuroPace
1/21/2025Initiated Coverage$11.97$17.00Buy